Stable Isotopically Labeled Intravenous Microdose Pharmacokinetic Trials as a Tool to Assess Absolute Bioavailability: Feasibility and Paradigm to Apply for Protein Kinase Inhibitors in Oncology.

Jeroen Roosendaal
Hilde Rosing
Jos H Beijnen

More about this publication

Clinical pharmacology in drug development

Volume 9
Issue nr. 5
Pages 552-559
Publication date 01-07-2020

Full text links

Publisher website (DOI) 10.1002/cpdd.840
Europe PubMed Central 32573110
Pubmed 32573110

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.